NOVARTIS AG NAMENS-AKTIEN SF 0,49
Technische Signale
| Signale Details | |
|---|---|
| WKN / ISIN | - / CH0012005267 |
| Börse | Hannover |
| Schluss | 80,10 |
| Konservatives Signal | - |
| MACD | - |
| Momentum | - |
| Bollinger Bands | - |
| TBI | - |
| Schnitt GD 90 | - |
Analystenbewertung
| Bewertungstrend | aktuell | Vorwoche | Vormonat |
|---|---|---|---|
| Bewertung | 2,67 | 2,65 | 2,67 |
| Anzahl der Analysten | 21 | 20 | 21 |
| Kaufen | 5 | 5 | 5 |
| Übergewichten | 0 | 0 | 0 |
| Halten | 14 | 13 | 14 |
| Untergewichten | 1 | 1 | 1 |
| Verkaufen | 1 | 1 | 1 |
| Aktueller Durchschnitt von insgesamt 21 Analysten: 2,67 | |||
| Planzahlen (in EUR) | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Umsatz | 46,66 Mrd. | 49,90 Mrd. | 52,11 Mrd. |
| EBIT | 9,17 Mio. | 18,70 Mrd. | 19,77 Mrd. |
| EBITDA | 16,87 Mio. | 19,77 Mrd. | 21,22 Mrd. |
| Nettoverschuldung** | 12,70 Mrd. | 12,91 Mrd. | 10,27 Mrd. |
Umsatz |
EBIT |
EBITDA |
Nettoverschuldung** |
| Dividende | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Dividende / Aktie | 3,03 EUR | 3,66 USD | 3,78 USD |
| Dividendenrendite | 2,99% | 3,45% | 3,56% |
Dividende / Aktie (in USD) |
Dividendenrendite (in %) |
||
| Analystenhäuser |
|---|
| AlphaValue,Argus Research Company,Axia Financial Research,Baader Helvea Equity Research,Bank am Bellevue,Bank Vontobel AG,Baptista Research,Barclays,BBVA Corporate and Investment Bank,Berenberg,BMO Capital Markets Equity Research,BNP Paribas Exane,BofA Global Research,Bryan Garnier & Co,CA Cheuvreux,Cantor Fitzgerald Ireland,CFRA Equity Research,Chardan Capital Markets, LLC,China Merchants Securities (HK) Co., Ltd,CIC Market Solutions (ESN),Citigroup Inc,Cleveland Research Company,Collins Stewart plc,Credit Suisse,Crisp Idea,Day By Day,Deutsche Bank,Dz Bank Ag,Equisights,Erste Group Bank AG,Eugene Investment & Securities Co Ltd.,Evolution Securities,Goldman Sachs,GSN North America,Guggenheim Securities, LLC,Hamburger Sparkasse AG,Helvea SA,HSBC,J.P. Morgan,Jefferies LLC,Kepler Capital Markets,Kepler Cheuvreux,Landesbank Baden-Wuerttemberg Equity and Fixed Income Research,Leerink Partners LLC,MF Global UK Limited,Miller Tabak & Co., LLC,Mirabaud Securities Limited,Mirae Asset Securities Co., Ltd.,Morgan Stanley,Morningstar Inc.,Natixis S.A.,New Street Research LLP,NH Investment & Securities Co., Ltd.,Nomura Securities Co. Ltd.,Norddeutsche Landesbank Girozentrale,NWM Strategy,ODDO BHF Corporate & Markets,Oppenheim Research GMBH,Oppenheimer & Co. Inc.,Panmure Liberum,Piper Sandler Companies,Raymond James Euro Equities,Redburn Atlantic,Sanford C. Bernstein & Co., LLC,Societe Generale Cross Asset Research,Stifel Europe,Stifel, Equities Research,TD Cowen,Truist Securities,UBS Investment Bank,UniCredit Research,WestLB AG,WGZ BANK AG Westdeutsche Genossenschafts,WhiteSand Research,Wolfe Research, LLC.,Zephirin Group, Inc.,Zürcher Kantonalbank |
| Hinweis |
|---|
|
Selected Data supplied by Standard & Poors
* Unabhängige Schätzung (Gewinnwachstum (in %)) ** Nettobargeldbestand bei negativen Schätzungen |